LC-MS analysis of vitamin D2/D3 in human plasma and serum
Application details
- Analysis and quantification of vitamin D2/D3 metabolites 25-hydroxyvitamin D2/D3 in two human patient plasma and serum samples via reversed phase LC-MS/MS.
- Samples were prepared via simple protein precipitation and two internal standards 2H3-25-OH vitamin D2/D3 were utilized.
- As complete elimination of endogenous levels of 25-OH Vitamin D2/D3 in human serum/plasma is impossible, deuterated 2H6-25-OH Vitamin D2/D3 were used.
- Standard curves were created from standard samples where ratio of deuterated 25-OH vitamin D2/D3 and two internal standards 2H3-25-OH vitamin D2/D3 were plotted against ratio of concentrations of the same.
Column | Purospher® STAR RP-18 endcapped (2μm) Hibar® HR 100-2.1 |
Injection volume | 10 μL |
Detection | APCI-MS/MS, MRM transitions: m/z 419.3/355.1, 416.3/358.1 (vitamin D2) and m/z 407.3/159.0, 404.3/162.0 (vitamin D3) |
Flow Rate | 0.4 - 0.5 mL/min |
Mobile Phase | A: Water, B: Methanol |
Gradient | see table |
Temperature | 50 °C |
Sample diluent (v/v) | Water |
Sample/sample preparation | Patient plasma and serum prepared with commercially available vitamin D kit. |
Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!